Refractory Marginal Zone Lymphoma

specific

A marginal zone lymphoma that does not respond to treatment.

23

Centers

7

Active Trials

$935K

Cancer Funding

Top Centers for Refractory Marginal Zone Lymphoma(23)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
67.1
2
NCI Comprehensive
Active Research Program
67.1
367.1
4
NCI Comprehensive
Active Research Program
67.1
5
NCI Comprehensive
Active Research Program
67.1
6
Active Research Program
67.1
7
Active Research Program
67.1
8
NCI Comprehensive
Active Research Program
62.1
9
NCI Comprehensive
44.6
10
NCI Comprehensive
44.6
11
NCI Comprehensive
44.6
1244.6
13
NCI Comprehensive
44.6
1444.6
15
NCI Comprehensive
44.6
16
NCI Comprehensive
44.6
17
NCI Comprehensive
44.6
18
NCI Comprehensive
44.6
1944.6
20
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
44.6
2144.6
22
NCI Comprehensive
44.6
2344.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →